Compare Chevron Corp (CVX) vs Medtronic PLC (MDT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Chevron Corp vs Medtronic PLC — how do they compare? Chevron Corp trades at $181.7 (market cap $361.99B), while Medtronic PLC trades at $79.3 (market cap $101.51B). The key difference: Chevron Corp is far larger — about 3.6× Medtronic PLC's market cap, and Chevron Corp pays the higher dividend (3.92%). Which is the better fit depends on your goals.
| CVX | MDT | |
|---|---|---|
Market Cap | $361.99B | $101.51B |
Volume | 9,807,834 | — |
Sector | Energy | Health |
52-Week High | $211.14 | $105.35 |
52-Week Low | $146.72 | $73.75 |
Enterprise Value | $402.09B | $120.25B |
Dividend Yield | 3.92% | 3.63% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVX trades at $181.77, up 3.04% today, with a bullish technical signal and strong analyst consensus. Recent earnings have consistently beaten estimates, though revenue and net income have declined year-over-year. The company maintains solid cash flow from operations and recently announced a $13.8 billion investment in Argentina's Vaca Muerta shale play, signaling growth commitment. High oil prices and geopolitical tensions are key near-term catalysts.
Outlook remains positive given Wall Street's $207.56 price target and 62% buy ratings, but risks include declining profit margins, volatile oil prices, and execution challenges on new projects. The stock offers value through dividends and strategic expansion, yet investors face headwinds from macroeconomic uncertainty and competitive pressures.
Medtronic (MDT) trades at $83.57, down 0.36% on the day, with a bullish technical outlook supported by moving averages and a consensus analyst price target of $97.50. The company reported strong revenue growth to $33.54B in 2025, with net income of $4.66B and a net margin of 13.2%. Recent acquisitions, such as Scientia Vascular (PRNewsWire, 2026-06-12), and consistent earnings beats highlight operational strength and strategic expansion in medical technology.
MDT presents a compelling investment case with a 3.5% dividend yield and undervalued metrics relative to growth, but faces risks from rising debt levels and margin pressures. Analyst sentiment is strongly bullish with 58% buy ratings, though investors should monitor execution on fiscal 2027 guidance and macroeconomic headwinds impacting healthcare spending.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Chevron Corp
Chevron Corporation is an integrated energy company with operations in countries located around the world. The Company produces and transports crude oil and natural gas. Chevron also refines, markets, and distributes fuels, as well as is involved in chemical and mining operations, power generation, and energy services.
Read more on CVX →About Medtronic PLC
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →
